Geriatric Endocrinology and Diabetes

Significant developments in wellbeing and social prosperity have prompted linear gains in life expectancy and a going with increment in the burden imposed by age-related morbidities. Complex adjustments in hormonal networks which control homeostasis and survival may underlie this poor adjustment to later life. Both the subclinical thyroid disease and menopause show the trouble in turning around endocrine changes in later life. In old age (≥60– 65 years of age), Diabetes mellitus is becoming a frightening public health issue. Among the geriatric population, type 2 diabetes is a growing issue, and the bigger extent of recently analysed diabetics is older. Treating diabetes among the elderly can introduce unique difficulties. Different disabilities related with ageing can add to the unpredictability of entirely self-managing diabetes. Among this age group, analysed diabetes is anticipated to achieve 26.7 million by 2050. The commonness of diabetes among elderly is anticipated to increase to 14% to 33% by 2050. Targeted interventions & extended surveillance and research and better arrangements are expected to address the quickly developing diabetes burden among older adults. In elderly with endocrine disorders, management will be person-centred and objectives of care will focus on change of function and quality of life inside the social context and care setting of the person.


    Related Conference of Geriatric Endocrinology and Diabetes

    December 09-10, 2019

    International Conference on Geriatrics and Ageing

    Bangkok, Thailand

    Geriatric Endocrinology and Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in